Moberg Pharma AB (publ) (ST:MOB) — Stock Price

Skr10.28 SEK
▲ 2.90% today

Moberg Pharma AB (publ) (ST:MOB) is currently trading at Skr10.28 SEK, up 2.90% today. Over the past 52 weeks, shares have ranged between Skr7.79 and Skr12.40. This page tracks Moberg Pharma AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Moberg Pharma AB (publ) market cap and net worth.

Moberg Pharma AB (publ) (MOB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Moberg Pharma AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Moberg Pharma AB (publ) Income Statement — Revenue, Profit & Earnings by Year

Moberg Pharma AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr13.54 Million Skr9.81 Million Skr273.15 Million Skr207.00K Skr209.68 Million
Cost of Revenue Skr5.86 Million Skr3.50 Million Skr2.10 Million Skr2.58 Million Skr2.58 Million
Gross Profit Skr7.68 Million Skr6.32 Million Skr-2.10 Million Skr-2.38 Million Skr-2.58 Million
Research & Development Skr3.54 Million Skr302.23 Million Skr2.38 Million Skr21.23 Million Skr21.89 Million
SG&A Skr32.14 Million Skr21.84 Million Skr20.78 Million Skr20.06 Million Skr18.44 Million
Total Operating Expenses Skr35.68 Million Skr331.14 Million Skr26.42 Million Skr20.72 Million Skr19.52 Million
Operating Income Skr-28.00 Million Skr-324.83 Million Skr-28.52 Million Skr-20.52 Million Skr-19.73 Million
EBITDA Skr-28.00 Million Skr-18.93 Million Skr-26.42 Million Skr-16.86 Million Skr-17.26 Million
EBIT — Skr-320.25 Million Skr-28.52 Million Skr-20.52 Million Skr-19.73 Million
Interest Expense Skr178.00K Skr228.00K Skr260.00K Skr71.00K Skr129.00K
Income Before Tax Skr-24.02 Million Skr-320.47 Million Skr-25.42 Million Skr-19.51 Million Skr-19.97 Million
Income Tax Expense Skr3.22 Million Skr-65.36 Million Skr-4.33 Million Skr-3.80 Million Skr-3.75 Million
Net Income Skr-27.24 Million Skr-255.11 Million Skr-21.09 Million Skr-15.71 Million Skr-16.22 Million

Moberg Pharma AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Moberg Pharma AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr682.26 Million Skr706.09 Million Skr634.73 Million Skr564.42 Million Skr450.89 Million
Total Current Assets Skr237.91 Million Skr300.11 Million Skr69.49 Million Skr127.76 Million Skr104.66 Million
Cash & Equivalents Skr28.33 Million Skr34.91 Million Skr49.25 Million Skr48.28 Million Skr36.60 Million
Short-term Investments — — — — —
Net Receivables Skr3.38 Million Skr804.00K Skr786.00K Skr1.44 Million Skr1.14 Million
Inventory Skr3.58 Million Skr4.29 Million Skr7.12 Million Skr700.00K Skr700.00K
Property, Plant & Equipment — — — Skr5.98 Million Skr4.52 Million
Goodwill Skr142.73 Million Skr207.53 Million Skr282.67 Million Skr131.84 Million Skr114.31 Million
Total Liabilities Skr17.04 Million Skr19.27 Million Skr24.01 Million Skr30.84 Million Skr16.84 Million
Total Current Liabilities Skr16.17 Million Skr16.72 Million Skr20.54 Million Skr26.79 Million Skr15.54 Million
Long-term Debt Skr0.00 Skr224.56 Million Skr247.50 Million Skr11.25 Million Skr65.00K
Net Debt Skr-227.53 Million Skr-289.15 Million Skr-55.82 Million Skr-118.75 Million Skr-98.02 Million
Total Stockholder Equity Skr665.22 Million Skr686.82 Million Skr610.73 Million Skr533.58 Million Skr434.05 Million
Retained Earnings Skr-620.88 Million Skr-593.64 Million Skr-338.53 Million Skr-317.44 Million Skr-301.73 Million

Moberg Pharma AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Moberg Pharma AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-17.49 Million Skr-16.47 Million Skr-33.20 Million Skr-16.84 Million Skr-15.30 Million
Capital Expenditures Skr17.49 Million Skr73.55 Million Skr124.12 Million Skr68.07 Million Skr31.31 Million
Free Cash Flow Skr-60.68 Million Skr-90.02 Million Skr-157.32 Million Skr-84.91 Million Skr-46.60 Million
Investing Cash Flow Skr-43.19 Million Skr-73.55 Million Skr-124.12 Million Skr-16.84 Million Skr-41.31 Million
Financing Cash Flow Skr-1.66 Million Skr322.76 Million Skr92.33 Million Skr107.81 Million Skr129.97 Million
Dividends Paid — — — — —
Stock-Based Compensation Skr5.69 Million Skr4.71 Million Skr2.31 Million Skr1.46 Million Skr631.00K
Depreciation Skr1.61 Million Skr301.32 Million Skr2.10 Million Skr2.58 Million Skr2.58 Million
Change in Cash Skr-62.34 Million Skr232.73 Million Skr-65.00 Million Skr22.89 Million Skr73.37 Million

Moberg Pharma AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track Moberg Pharma AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 11, 2026 — — —
Feb 09, 2026 -0.27 — —
Nov 11, 2025 -0.09 -0.10 +10.00%
Aug 12, 2025 -0.16 -0.10 -60.00%
May 13, 2025 -0.06 — —
Feb 11, 2025 1.21 -0.12 +1108.33%
Nov 12, 2024 -0.03 -0.10 +70.00%
Aug 13, 2024 -0.13 — —